In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 3, 1999, Pages 403-406

  Giacometti, Andrea ^b   Cirioni, Oscar ^a   Barchiesi, Francesco ^b   Caselli, Francesca ^b   Scalise, Giorgio ^b  

^a Azienda Ospedaliera Umberto I   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; MAGAININ 2; PEPTIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CRYPTOSPORIDIUM PARVUM; MINIMUM INHIBITORY CONCENTRATION; PNEUMOCYSTIS CARINII; YEAST;

ANIMALS; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CANDIDA; CATIONS; COCCIDIOSTATS; CRYPTOSPORIDIUM PARVUM; DRUG EVALUATION, PRECLINICAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTIDES, CYCLIC; PNEUMOCYSTIS; POLYAMINES; XENOPUS PROTEINS;

EID: 0032885379     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.3.403     Document Type: Article

References (8)

1. Cannon, M. (1987). Antimicrobial peptides. A family of wound healers. Nature 328, 478.
2. Hancock, R. E. W. (1997). Antibacterial peptides and the outer membranes of Gram-negative bacilli. Journal of Medical Microbiology 46, 1-3.
3. Cirioni, O., Giacometti, A. & Scalise, G. (1997). In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii, Journal of Antimicrobial Chemotherapy 39, 45-51.
4. Giacometti, A., Cirioni, O. & Scalise, G. (1996). In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. Journal of Antimicrobial Chemotherapy 38, 399-408.
5. National Committe for Clinical Laboratory Standards. (1995). Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts: Approved Standard M27-A. NCCLS, Villanova, PA.
6. Upton, S. J., Tilley, M., Nesterenko, M. V. & Brillhart, D. B. (1994). A simple and reliable method of producing in-vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiology Letters 118, 45-50.
7. Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995). Resistance of Candida species to fluconazole. Antimicrobial Agents and Chemoherapy 38, 1-8.
8. Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S. & Rahal, J. J. (1986). Cryptococcal disease in patients with acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Annals of Internal Medicine 104, 234-40.